SIGA Technologies, Inc.
- FDA Approves TPOXX (tecovirimat) as the First Drug for the Treatment of Smallpox - July 13, 2018
- SIGA Technologies Announces Favorable Outcome of Advisory Committee In Support of TPOXX - May 1, 2018
- SIGA Technologies Announces FDA Accepts NDA and Grants Priority Review for Oral TPOXX to Treat Smallpox - February 7, 2018
- SIGA Technologies Announces FDA Submission of its New Drug Application for oral TPOXX (tecovirimat) to Treat Smallpox - December 11, 2017
Drugs Associated with SIGA Technologies, Inc.
SIGA Technologies, Inc. manufactures, markets and/or distributes 1 drug in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.